This topic contains a solution. Click here to go to the answer

Author Question: After administering glimepiride, the nurse would assess the client for which of the following? ... (Read 288 times)

RODY.ELKHALIL

  • Hero Member
  • *****
  • Posts: 591
After administering glimepiride, the nurse would assess the client for which of the following? Select all that apply.
 
  A) Lactic acidosis
  B) Edema
  C) Hypoglycemia
  D) Heartburn
  E) Nausea

Question 2

Which of the following produce their glucose-lowering effect by decreasing insulin resistance and increasing insulin sensitivity? Select all that apply.
 
  A) Rosiglitazone (Avandia)
  B) Metformin (Glucophage)
  C) Pioglitazone (Actos)
  D) Miglitol (Glyset)
  E) Acarbose (Precose)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kkenney

  • Sr. Member
  • ****
  • Posts: 352
Answer to Question 1

Ans: C, D, E
Feedback:
Adverse reactions associated with sulfonylureas, like glimepiride (Amaryl), include hypoglycemia, anorexia, nausea, vomiting, epigastric discomfort, weight gain, heartburn, and various vague neurologic symptoms, such as numbness and weakness of the extremities.

Answer to Question 2

Ans: A, C
Feedback:
The thiazolidinediones, rosiglitazone (Avandia) and pioglitazone (Actos), produce their glucose-lowering effect by decreasing insulin resistance and increasing insulin sensitivity. The alpha-glucosidase inhibitors, acarbose (Precose) and miglitol (Glyset), produce their glucose-lowering effects by delaying the digestion and absorption of carbohydrates in the intestine. Metformin sensitizes the liver to circulating insulin levels and reduces hepatic glucose production.





 

Did you know?

Vaccines cause herd immunity. If the majority of people in a community have been vaccinated against a disease, an unvaccinated person is less likely to get the disease since others are less likely to become sick from it and spread the disease.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Individuals are never “cured” of addictions. Instead, they learn how to manage their disease to lead healthy, balanced lives.

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

For a complete list of videos, visit our video library